Goldman Sachs Removes CIGNA (CI), Adds Humana (HUM) to Conviction Buy List
More News related to CI
- David Moenning's Daily State of the Markets: 9/10
- CIGNA International Releases New Transactional Web Portal; Medical Translations, Online Weight Management Offered
- Houston Northwest Medical Center Awarded 11 CIGNA HealthCare Quality Designations
- The Shaky Economy: Is it Changing the Way People Take Care of Their Health?
- CIGNA Expands Reporting of Its Quality Scores as Part of Efforts to Improve the U.S. Health Care System
More News related to HUM
- David Moenning's Daily State of the Markets: 9/10
- Humana Introduces New Individual Health Insurance Plans In Nevada
- Humana's new Guidance Center Opens in East Orlando
- Humana Veterans Healthcare Services Sponsors Second Emerald Coast Honor Flight
- Humana Inc. to Release Third Quarter Results on November 3, 2008
More News related to Analyst Comments
- AmTech Reiterates Sell on Amazon (AMZN); Cuts PT to $45
- Canaccord Adams Maintains 'Buy' Rating on VALE (RIO), but Lowers Price Target
- Canaccord Adams Maintains 'Buy' Rating on Thompson Creek Metals (TC)
- Canaccord Adams Maintains 'Buy' Rating on Taseko Mines Limited (TGB)
- Analyst Starts Coverage on Solar Sector with an Underperform; Sees Stocks Falling At Least Another 30-40%
Goldman Sachs removes CIGNA Corp. (NYSE: CI) from its Conviction Buy List, while at the same time adding Humana (NYSE: HUM) to its Conviction Buy List.
CIGNA Corporation provides health care and related benefits in the United States and internationally.
Humana, Inc. provides various health and supplemental benefit plans for employer groups, government benefit programs, and individuals in the United States.
Related Categories
Analyst CommentsStocks Mentioned
-2.54Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
